Search results for '**' (4 products)

4 Item(s)

This Vital Signs issue discusses the Danaher's acquisition of Cepheid for nearly $4 Billion in cash, and Orphan Drug Expenditures in the United States: A Historical and Prospective Analysis, 2007–2013.

USD 600.00

USD 450.00 save 25 %

This Vital Signs issue discusses the clinical diagnostics laboratory tests payment system, approval of a Zika test kit, the impact on innovation of mergers in the pharma/biotech industry, and national healthcare expenditure projections through 2025.

USD 600.00

USD 450.00 save 25 %

05 May 2015  |  Asia Pacific

Market Trends - Digitalisation, Decentralisation and Democratisation of Healthcare in Australia

A Market Insight by Frost & Sullivan

Frost & Sullivan presented the 2015 Australia Healthcare Outlook at a live event in Sydney in March. This document compiles key trends and opinions presented at the event with supporting data and figures. 2015 predictions in the areas of healthcare financing, aged care, primary care, and emerging technologies have been detailed here.

USD 850.00

USD 637.50 save 25 %

04 May 2015  |  Asia Pacific

Market Trends - Technologies to Reduce Healthcare System Fragmentation in Australia

A Market Insight by Frost & Sullivan

Frost & Sullivan presented the 2015 Australia Healthcare Information Technology (IT) Outlook at a live event in Sydney in March. This document compiles key trends and opinions presented at the event with supporting data and figures. 2015 predictions highlight key challenges and unmet healthcare industry needs that can be addressed through meaningfu...

USD 850.00

USD 637.50 save 25 %

4 Item(s)